Functional Dissection of Systemic Lupus Erythematosus Using Congenic Mouse Strains

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 6019-6028

  Morel, Laurence ^a   Mohan, Chandra ^a   Yu, Ying ^a   Croker, Byron P ^a,b   Tian, Nana ^a   Deng, Alicia ^a   Wakeland, Edward K ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MESSENGER RNA;

ANIMAL; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CELL LINEAGE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NEW ZEALAND BLACK MOUSE; PHENOTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; CELL LINEAGE; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; PHENOTYPE; RNA, MESSENGER;

EID: 0031570375     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Braverman, I. M. 1968. Study of autoimmune disease in New Zealand mice. I. Genetic features and natural history of NZB, NZY, and NZW strains and NZB/ NZW hybrids. J. Invest. Dermatol. 50:483.
2. Theofilopoulos, A. N. 1992. Murine models of systemic lupus erythematosus. In Systemic Lupus Erythematosus, R. G. Lahita, ed. Churchill Livingstone, New York, p. 121.
3. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219.
4. Drake, C. G., S. K. Babcok, E. Palmer, and B. L. Kotzin. 1994. Genetic analysis of the NZB contribution to lupus-like autoimmune disease. Proc. Natl. Acad. Sci. USA 91:4062.
5. Drake, C. G., S. J. Rozzo, H. F. Hirschfeld, N. P. Smarnworawong, E. Palmer, and B. L. Kotzin. 1995. Analysis of the NZB contribution to lupus-like renal disease: multiple genes that operate in a threshold manner. J. Immunol. 154:2441.
6. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91:10168.
7. z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice: origins and initial characterization. Lab. Invest. 68:419.
8. Mohan, C. and S. K. Datta. 1995. Lupus: key pathogenic mechanisms and contributing factors. Clin. Immunol. Immunopathol. 77:209.
9. Raveche, E. S., E. A. Novotny, C. T. Hansen, J. H. Tjio, and A. D. Steinberg. 1981. Genetic studies in NZB mice. V. Recombinant inbred lines demonstrate that separate genes control autoimmune phenotype. J. Exp. Med. 153:1187.
10. Snell, G. D. 1948. Methods for the study of histocompatibility genes. J. Genetics 49:87.
11. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying SLE-susceptibility genes derived from the SLE-prone NZM/Aeg2410 strain. Mamm. Genome 7:335.
12. Mohan, C., L. Morel, P. Yang, and E. K. Wakeland. 1997. Genetic dissection of SLE pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. In press.
13. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosomes: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
14. Hylkema, M. N., H. Huygen, C. Kramers, T. J. v. d. Walls, J. de Jong, M. C. van Bruggen, A. J. Swaak, J. H. Berden, and R. J. Smeenk. 1994. Clinical evaluation of a modified ELISA, using photo-biotinylated DNA, for the detection of anti-DNA antibodies. J. Immunol. Methods 170:93.
15. Yager, T. D., C. T. McMurray, and K. E. Van Holde. 1989. Self induced release of DNA from nucleosome core particle. Biochemistry 28:2271.
16. Ishigatsubo, Y., A. D. Steinberg, A. Krieg, and D. M. Klinman. 1995. Increased utilization of polyreactive B cells during periods of generalized immune activation. Autoimmunity 22:113.
17. Barnes, R. D., and M. Tuffrey. 1967. Serum antinuclear factor and the influence of environment in mice. Nature 214:1136.
18. Siegel, B. V., M. Brown, and J. I. Morton. 1972. Detection of antinuclear antibodies in NZB and other mouse strains. Immunology 22:457.
19. Eisenberg, R. A., S. Y. Craven, C. L. Fisher, S. C. Morris, R. Rapoport, D. S. Pisetsky, and P. L. Cohen. 1989. The genetics of autoantibody production in MRL/lpr mice. Clin. Exp. Rheumatol. 7:S35.
20. Kotzin, B. L., and J. R. O'Dell. 1995. Systemic lupus erythematosus. In Samter's Immunological Diseases. M. M. Frank, K. F. Austen, H. N. Claman, and E. R. Unanue, eds. Little, Brown and Company, Boston, p. 667.
21. Slack, J. H., L. Hang, J. Barkley, R. J. Fulton, L. D'Hoostelacre, A. Robinson, and F. J. Dixon. 1984. Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice. J. Immunol. 132:1271.
22. Fisher, C. L., R. A. Eisenberg, and P. L. Cohen. 1988. Quantitation and IgG subclass distribution of anti-chromatin autoantibodies in SLE mice. Clin. Immunol. Immunopathol. 46:205.
23. Seldin, M. F. 1996. Mouse chromosome 1. Mamm. Genome 6:S28.
24. Cook, L., and V. Agnello. 1992. Complement deficiency and systemic lupus erythematosus. In Systemic Lupus Erythematosus. R. G. Lahita, ed. Churchill Livingstone, New York, p. 569.
25. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
26. Lynch, D. H., M. L. Watson, M. R. Anderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin, and M. F. Seldin. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
27. Roths, J. B., E. D. Murphy, and E. N. Eicher. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1.
28. Brilliant, M. H., R. W. Williams, B. C. Holdener, and J. M. Angel. 1996. Mouse chromosome 7. Mamm. Genome 6:S135.
29. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetrapolin (TTP) deficiency. Immunity 4:445.
30. Prochazka, M., D. V. Serreze, S. M. Worthen, and E. H. Leiter. 1989. Genetic control of diabetogenesis in NOD/Lt mice: development and analysis of congenic stocks. Diabetes 38:1446.
31. Prins, J. B., J. A. Todd, N. R. Rodrigues, S. Ghosh, P. M. Hogarth, L. S. Wicker, E. Gaffney, P. L. Podolin, P. A. Fisher, A. Sirotina, and L. Peterson. 1993. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 260:695.
32. Wicker, L. S., J. A. Todd, J. B. Prins, P. L. Podolin, R. J. Renjilian, and L. B. Peterson. 1994. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J. Exp. Med. 180:1705.
33. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180:1553.
34. Puel, A., P. C. Groot, M. G. Lathrop, P. Demant, and D. Mouton. 1995. Mapping of genes controlling quantitative antibody production in Biozzi mice. J. Immunol. 154:5799.
35. Wu, J.-M., J. A. Longmate, G. Adamus, P. A. Hargrave, and E. K. Wakeland. 1996. Interval mapping of quantitative trait loci controlling humoral immunity to exogenous antigens: evidence that non-MHC Ir genes may also influence susceptibility to autoimmunity. J. Immunol. 157:2498.
36. Steel, D. M., and A. S. Whitehead. 1994. The major acute phase reactants: C-reactive protein, serum amyloid P component, and serum amyloid A protein. Immunol. Today 15:81.
37. Drake, C. G., S. J. Rozzo, T. J. Vyse, and B. L. Kotzin. 1996. Absence of coding sequence polymorphism in the serum amyloid P component (Sap) in autoimmune New Zealand black mice. Mamm. Genome 7:466.
38. Law, C. L., S. P. Sidorenllo, and E. A. Clark. 1994. Regulation of lymphocyte activation by the cell surface molecule CD22. Immunol. Today 15:442.
39. 2 microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA 93:5512.
40. Ghosh, S., S. M. Palmer, N. R. Rodrigues, H. J. Cordell, C. M. Hearne, R. J. Cornall, J. B. Prins, P. McShane, M. G. Lathrop, L. B. Peterson, L. S. Wicker, and J. A. Todd. 1993. Polygenic control of autoimmune diabetes in non-obese diabetic mice. Nature Genetics 4:404.